Clinical Trial: A prospective, randomized, double-blind, controlled study on the use of botulinum toxin type A for preventing incision scars in abdominoplasty. (China)

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, randomized, double-blind, controlled study on the use of botulinum toxin type A for preventing incision scars in abdominoplasty.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130573

Registration Time: 2026/08/21

Type: Interventional study

Primary Sponsor: Affiliated Hospital of Zunyi Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=308835

Published by HT Digital Content Services with permission from Health Daily Digest....